Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00548392 · ClinicalTrials.gov registry record
Sonographic Visibility of Breast Biopsy Marker Clips Up to 4 Weeks After Placement
A clinical trial, sponsored by Fred Hutchinson Cancer Center.
- Completed
- Registry status
- 25
- Enrollment target
NCT00548392: Completed study, sponsored by Fred Hutchinson Cancer Center.
NCT00548392 is a clinical trial that has completed, run by Fred Hutchinson Cancer Center. The registered enrollment target is 25 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00548392 has completed, sponsored by Fred Hutchinson Cancer Center.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
Study Summary
The purpose of this study is to determine how long collagen based marker clips remain visible by ultrasound after placement in suspicious breast lesions and if collagen based marker clips can be reliably identified in the operating room and serve as effective guidance for surgical removal of high risk or malignant breast lesions.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2007-05 |
| Est. Completion | 2008-09 |
What the finished NCT00548392 record still lists
NCT00548392 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00548392 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00548392 about?
NCT00548392 is a clinical study titled "Sonographic Visibility of Breast Biopsy Marker Clips Up to 4 Weeks After Placement". The purpose of this study is to determine how long collagen based marker clips remain visible by ultrasound after placement in suspicious breast lesions and if collagen based marker clips can be reliably identified in the operating room and serve as effective guidance for surgical removal of high ri...
What is the current status of trial NCT00548392?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2007-05. Estimated completion is 2008-09.
Who is sponsoring clinical trial NCT00548392?
This trial is sponsored by Fred Hutchinson Cancer Center, which has 483 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia